April 18, 2019 Joel Wood, SVP, Government Affairs and Joel Kopperud, VP, Government Affairs, give us the lowdown on AHPs, the ACA, Medicare for All and drug pricing—and what we can
March 21, 2019 The Council’s Katie Oberkircher spoke with Eric Pachman and Antonio Ciaccia, co-founders of 46Brooklyn—a prescription drug research firm—to demonstrate how to use the tools they’ve created to
March 21, 2019 Our Government Affairs team is monitoring bills and action items that would affect the insurance industry. Here’s what we’re focusing on as of late: The “Short on
March 15, 2019 The Council’s expert legal team at Steptoe & Johnson created a chart to show the broad landscape of drug pricing legislation in Congress. The chart is updated
The main topic of discussion? How to demonstrate the effectiveness of the employer-sponsored insurance system within a growing national dialogue on government-run healthcare.
The team at NFP resets the dialogue on government-run health systems by exploring how they work in the UK, Canada and here in the U.S. within the Veterans Affairs (VA) program.
January 25, 2019 We attended the Council for Affordable Health Coverage’s premier policy event earlier this month to hear from representatives from all corners of the healthcare industry. HHS Secretary
December 5, 2018 Tech companies are banging down the doors of the healthcare industry, infiltrating different pieces of a complicated system in an effort to inject innovation into care delivery
December 5, 2018 Legislative and regulatory efforts to reduce drug costs is a top priority for both Democrats and Republicans in the next Congress, and it’s one of the few
November 8, 2018 Despite the Trump administration’s push to lower drug prices, costs have not yet decreased. Lack of consensus regarding how to approach the complex pharmacy supply chain has
